Informations:
Erreur:
Mots-clés
Myelodysplasias, Hematopoetic ×
- Registries (9)
- Bone Marrow (1)
- Registration (1)
- Documentation (1)
- Eligibility Determination (1)
- Hematology (1)
- Laboratories (1)
- Leukemia (1)
- Medical History Taking (1)
Table des matières
Modèles de données sélectionnés
Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.
9 Résultats de recherche.
Groupes Item: Registration form, Lead times, Diagnosis, Biobank, PREVIOUS DISEASE, Transfusions, Blood samples at diagnosis, Bone marrow at diagnosis, Cytogenetics at diagnosis, IPSS, Diagnosis reason, Treatment, Follow-Up
Myelodysplastic Syndrome - Follow-Up
10 Groupes Item 83 Eléments de données Groupes Item: Demographic data, Classification, Hematological findings, Bone marrow smear, Bone marrow biopsy, Karyotype and Prognosis, Treatment, Follow-Up – Progress
Groupes Item: Administrative data, Symptoms at initial diagnosis, Comorbidity at initial diagnosis, Comorbidity Follow up, Laboratory at initial diagnosis, Laboratory follow-up, Follow up, Disease progression, Blood cell morphology, Cellular Morphology Bone marrow, Histology Bone Marrow, Molecular Genetics, secondary myelodysplastic syndromes, Therapy Myelodysplastic syndrome, Treatment
Groupe Item: Patient registration
Eligibility
1 Groupe Item 5 Eléments de donnéesVisit details
6 Groupes Item 29 Eléments de donnéesBone marrow assessment
3 Groupes Item 13 Eléments de donnéesConcomitant treatment
1 Groupe Item 5 Eléments de donnéesWithdrawal
2 Groupes Item 7 Eléments de donnéesGeneral medical history
1 Groupe Item 5 Eléments de données Groupes Item: Patient records, Data sources, Tumor data, Diagnostic data, Treatment data, Chemotherapy, Stem Cell Transplantation
Groupes Item: Patient, Diagnostic Data, Peripheral Blood, Bone Marrow, Course, Current Status, Lab analytics, Therapies, Transfusions, Ferritin levels, Chelation treatment, Comments
Groupes Item: Follow Up, Patient last seen, Graft versus Host Disease (GvHD) since last report, Other Complications since last report, Other Complications since last report, Secondary Malignancy, Lymphoproliferative or Myeloproliferative disorder, Additional therapies since last follow up, First evidence of relapse or progression since last HSCT, Last disease and pateint status, Additional notes if applicable, Identification and Signature
Groupes Item: Initial Diagnosis, Initial Diagnosis - Cytogenetics - Chromosome Analysis, Initial Diagnosis - Haematological values, First Line Therapy, Subclassification & Status of Disease at HSCT, Disease Status at HSCT, Cytogenetics Data, Haematological values at HSCT, Additional Treatment Post-HSCT, Best Disease Response at 100 days post-HSCT, Forms to be filled in
Groupes Item: Team, Patient, Disease